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Abstract
Inflammatory bowel disease (IBD) development 
is affected by complex interactions between envi-
ronmental factors, changes in intestinal flora, various 
predisposing genetic properties and changes in the 
immune system. Dietary factors seem to play an 
underestimated role in the etiopathogenesis and 
course of the disease. However, research about food 
and IBD is conflicting. An excessive consumption of 
sugar, animal fat and linoleic acid is considered a risk 
factor for IBD development, whereas a high fiber diet 
and citrus fruit consumption may play a protective 
role. Also, appropriate nutrition in particular periods 
of the disease may facilitate achieving or prolonging 
remissions and most of all, improve the quality of 
life for patients. During disease exacerbation, a low 
fiber diet is recommended for most patients. In the 
remission time, an excessive consumption of alcohol 
and sulfur products may have a negative effect on the 
disease course. Attempts are also made at employing 
diets composed in detail in order to supplement 
IBD therapy. A diet with a modified carbohydrate 
composition, a semi-vegetarian diet and a diet low 
in fermentable oligosaccharides, disaccharides, 
monosaccharides and polyols are under investigation. 
Due to chronic inflammation as well as side effects of 
chronically used medications, patients with IBD are 
also at increased risk of nutritional factor deficiencies, 
including iron, calcium, vitamin D, vitamin B12, folic 
acid, zinc, magnesium and vitamin A. It should also 
be remembered that there is no single common diet 
suitable for all IBD patients; each of them is unique 
and dietary recommendations must be individually 
developed for each patient, depending on the course 
of the disease, past surgical procedures and type of 
pharmacotherapy.
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Core tip: The role of dietary factors in inflammatory 
bowel diseases (IBD) development seems to be 
underestimated although approximately 70% of 
IBD patients are known to employ elimination diets 
while in remission, affecting their social and family 
life. We would like to draw attention to this growing 
problem. The objective of our paper is to present up 
to date information regarding the effect of diet on IBD 
morbidity and course, together with the effect of IBD 
on the nutritional status of patients.
Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach 
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Ulcerative colitis (UC) and Crohn’s disease (CD) 
are types of inflammatory bowel diseases (IBD). 
IBD constitutes chronic conditions, the etiology of 
which is not yet fully understood, and their course 
is characterized by periods of exacerbation and 
remission[1-3]. In spite of their similar properties, 
UC and CD differ in their risk factors and genetic 
predispositions, and in their clinical, endoscopic 
and histological images[2]. In UC, the inflammatory 
process solely involves the mucosa and extends by 
continuity, starting from the rectum. A characteristic 
symptom of UC is bloody diarrhea that may be 
accompanied by abdominal pain or fever[2]. Moreover, 
patients in whom the inflammatory process is seen 
in the rectum only may develop constipation during 
the exacerbation periods of the disease. In CD, the 
inflammatory process involves the entire wall of the 
gastrointestinal tract and it is propagated segmentally, 
not by continuity, from the oral cavity to the rectum[4]. 
Characteristic symptoms of CD are abdominal pain, 
fever, loss of body mass, anemization and diarrhea[5].
While both conditions affect the gastrointestinal 
system, the role of diet in their course is often 
underestimated. Specifically, a literature analysis 
of the importance of environmental factors in the 
etiopathogenesis of IBD concluded that nutrition is an 
undervalued factor affecting IBD development.
During IBD exacerbation periods, recommending 
a low fiber diet is unquestionable[6]. However, 
recommendations addressing the nutrition of patients 
in IBD remission remain controversial. As many as 
70% of IBD patients are known to employ elimination 
diets during remission to avoid exacerbation of the 
disease, which affects both their social and family life[7]. 
Such a high percentage of IBD patients employing 
dietary restrictions during remission has not been 
confirmed by the recommendations formulated by 
various gastroenterology organizations[8-11]. In their 
recommendations for CD patients, the National Clinical 
Guideline Center advise a diversified and well balanced 
diet, without addressing a detailed composition[11].
Patients with IBD should follow a diet that supplies 
an appropriate amount of energy, iron, calcium, 
zinc, folic acid and vitamins D and B12[12]. Vitamin 
D deficiency is of particular importance as it may 
exacerbate the course of IBD and is additionally 
associated with an increased morbidity rate[13,14].
Studies have also investigated diets of different 
compositions aimed to supplement therapy during 
periods of exacerbation, such as a modified car-
bohydrate diet (SCD) or a low fermentable oligo-
saccharides, disaccharides, monosaccharides and 
polyols diet (FODMAP)[15,16].
Additional supplementation with probiotics or 
unsaturated omega-3 fatty acids has been also assessed 
with respect to its effect on shortening exacerbation 
periods or prolonging remission duration[17,18].
Numerous studies have attempted to demonstrate 
an association between IBD occurrence and dietary 
excess or deficiency of given foods[4]. Dietary factors 
that may increase the risk of developing UC and 
CD include a high consumption of saturated fat and 
monosaccharides and a low consumption of fiber[5,19,20].
The objective of this paper is to present the effects 
of diet on IBD course and morbidity, as well as to 
explore the effect of IBD on the nutritional status 
of patients. The presented results may be helpful in 
planning a diet for IBD patients.
ENvIRONmENTal faCTORs aND 
INCIDENCE Of IBD
The incidence of IBD depends on numerous factors 
that are not fully understood. IBD development is 
affected by complex interactions between environ-
mental factors, changes in intestinal flora, various 
predisposing genetic properties and changes in the 
immune system[2,4].
The contribution of environmental factors is 
supported by an increased incidence of IBD in deve-
loped countries and urban populations, as opposed 
to developing countries and rural populations[2]. In 
addition, some authors have drawn attention to an 
increased IBD incidence in countries with previously 
lower morbidity rates, such as countries in Asia. The 
investigators associate this effect with changes in the 
lifestyles of such populations.
Moreover, the effect of tobacco smoking on IBD 
development is well documented[1,4,21]. Active smoking 
is an environmental factor that affects IBD incidence 
in two ways. It may exert a protective effect against 
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UC, while it increases the risk of CD development[22,23]. 
However, in their meta-analysis, Jones et al[24] did not 
observe a correlation between passive smoking in 
childhood and IBD incidence.
Interesting reports address the importance of 
breastfeeding in IBD development. According to 
the meta-analysis performed by Klement et al[25], 
breastfeeding may be a protective factor in IBD 
morbidity. The authors suggest the necessity of 
performing further studies in order to confirm this 
hypothesis. Nevertheless, encouraging breastfeeding, 
especially in families affected by IBD, is warranted.
A literature analysis assessing the role of envi-
ronmental factors in the etiopathogenesis of IBD 
highlights that diet is an underestimated factor 
affecting its development.
NUTRITIONal faCTORs IN THE 
ETIOlOGY Of IBD
Many attempts have been made at associating the 
incidence of IBD with dietary excess or deficit of 
various foods[4]. Indeed, a high intake of saturated fats 
and monosaccharides and a low intake of fiber are 
linked with increased risk of CD development[19].
Monosaccharides and sweets
Numerous studies have emphasized the effect of an 
excessive consumption of dietary monosaccharides 
on IBD development. In retrospective studies, 
patients with CD showed an increased consumption 
of monosaccharides prior to feeling ill[5,26]. Russel et 
al[27] emphasized the effect of consuming cola-type 
drinks and chocolate on increasing IBD incidence. 
Their observations were confirmed by Sakamoto et 
al[20], who demonstrated a negative effect of sweets 
and artificial sweeteners on the risk of developing both 
UC and CD. However, in 2014, Chan et al[28] presented 
results of a large prospective study of over 400000 
men and women that demonstrated no association 
between total intake of carbohydrates, sugar or starch 
and incidence of UC or CD.
It should be stressed that lactose consumption 
does not increase the risk of IBD[26].
Proteins and fats
According to Reif et al[26], an increased consumption of 
animal protein may result in a low degree of increased 
risk of IBD development. The same authors also 
demonstrated that a high fat diet, particularly one 
rich in cholesterol and animal fats, may increase IBD 
incidence[26]. In their study, Ananthakrishnan et al[29] 
confirmed the effect of an increased consumption of 
trans fatty acids on the risk of UC development. The 
effect of consumption of linoleic acid, a polyunsaturated 
omega-6 fatty acid, on the risk of UC development 
has been also demonstrated. This fatty acid is a 
precursor of arachidonic acid (AA), the metabolites 
of which exhibit pro-inflammatory properties[30]. AA 
consumption may also increase UC risk, while an 
increased supply of oleic acid, a monounsaturated 
fatty acid, is a preventive factor[31]. Based on a study 
of 25639 participants that completed a 7 d food 
diary, John et al[32] demonstrated a protective effect 
of unsaturated omega-3 fatty acid consumption on 
UC incidence; specifically, dietary intake of doco-
sahexaenoic acid exerted beneficial effects. These 
observations have since been confirmed in publications 
by other authors[29]. Based on studies carried out in 
Japan, Sakamoto et al[20] indicated a negative effect of 
total consumption of fats and unsaturated fatty acids 
on the risk of IBD development.
Fiber
Fiber consumption exerts a protective effect on IBD 
development as a high fiber diet decreases the risk 
of developing IBD[26]. According to Ananthakrishnan 
et al[33], a diet with a fiber content of 24.3 g/d may 
decrease the risk of CD development by 40%. A 
particularly positive effect was noted with fiber 
originating from fruit sources. However, the authors 
did not observe any protective effect against UC 
development. In a study of 130 individuals under 
30 years of age, Amre et al[34] confirmed the role of 
dietary fiber consumption on the prevention of CD.
Vitamins and minerals
Vitamin D deficiency is a common phenomenon in 
patients with IBD. As such, some authors regard this 
deficiency as a dietary factor that may increase the 
risk of IBD development[13]. Reif et al[26] pointed to the 
protective effect of diets rich in fluids, magnesium and 
vitamin C on IBD risk; on the other hand, retinol-rich 
products may facilitate IBD development. It should 
be emphasized that fruit consumption, in view of the 
fiber and vitamin C content, may constitute a separate 
nutritional factor that decreases the risk of developing 
IBD[26,33,34]. Fruit juices may also be recommended 
due to their anti-inflammatory and anti-oxidative 
activity[35]. Russel et al[27] focused particularly on the 
beneficial effect of consuming citrus fruits.
Alcohol
Some studies have demonstrated a protective effect of 
alcohol consumption with respect to UC development. 
Nevertheless, this effect is negated when drinking 
alcohol is combined with cigarette smoking[36]. No 
significant differences were observed in CD deve-
lopment between individuals consuming alcohol at 
least four times a week and teetotalers[37].
DIET DURING pERIODs Of DIsEasE 
ExaCERBaTION
Recommendations for low fiber intake are un-
questionable in patients with exacerbated IBD, 
Owczarek D et al . Diet and nutritional factors in IBD
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diarrhea or abdominal pain[6]. However, this does 
not apply to patients with UC and rectal involvement 
only who may develop constipation. Such patients 
are advised to be on a fiber rich diet, in keeping with 
the recommendations of the World Gastroenterology 
Organization[6]. According to the recommendations 
of the European Crohn’s and Colitis Organization 
(ECCO), pediatric patients with exacerbated UC of mild 
to moderate intensity are advised to be on a normal 
diet[10]. Patients with inadequate nutritional supply 
may be recommended to remain on exclusive enteral 
nutrition (EEN) with liquid preparations containing all 
the necessary nutrients[10,38]. In keeping with the ECCO 
recommendations, in case of UC, EEN does not play a 
therapeutic role[10]. On the other hand, EEN may result 
in CD remission. In a review of studies addressing EEN 
employment in children, its effectiveness in achieving 
remission was equal to that of glucocorticosteroid 
therapy[39]. In adult patients, the results were 
somewhat less encouraging. The meta-analysis per-
formed by Zachos et al[40] indicated the advantage 
of glucocorticosteroids over EEN in achieving CD 
remission. The authors did not demonstrate any 
differences between the effectiveness of elemental and 
polymeric diets[40]. EEN was also shown to accelerate 
gastrointestinal mucosal healing in pediatric patients 
with CD[41]. It is important to gradually introduce a 
normal diet after 8 wk of EEN feeding. The introduction 
of a normal diet should span approximately 7-10 d, 
with one meal introduced every 3-4 d[38].
DIET DURING REmIssION pERIODs
The nutritional model presented above for patients 
with exacerbated IBD remains undisputed. However, 
recommendations addressing the diet of patients 
in remission are not unambiguous. According to 
Zallot et al[7], as many as 2/3 of IBD patients employ 
an elimination diet to avoid disease exacerbation. 
Such behavior affects their social life by limiting the 
occasions when meals are eaten outside the home 
or in eating different meals to other household 
members. In spite of such phenomena, numerous 
official recommendations do not address the subject 
of nutrition of IBD patients. This is additionally 
complicated by the fact that investigations carried out 
by various authors present contradictory results. The 
next section of this report discusses recommendations 
presented by various scientific societies as well as the 
results of studies that may be helpful in planning a diet 
for IBD patients.
Recommendations of scientific associations
The body of recommendations of the American 
College of Gastroenterology addressing UC do not 
include dietary recommendations[8] and only address 
nutrition during CD exacerbation periods[9]. For the 
management of pediatric UC patients, ECCO does not 
advise the use of any special diets and supplements 
due to their lack of effect on the disease course[10]. 
However, the recommendations for nutritional manage-
ment of CD from the National Clinical Guideline Center 
advise patients in remission to be on a diversified 
and well-balanced diet, but do not address a detailed 
composition[11].
Results of other publications
In a review, Akobeng et al[42] pointed to the role of 
enteral nutrition in prolonging periods of remission in 
patients with CD. Beneficial effects were achieved by 
providing 35%-50% of calorie requirements by means 
of enteral nutrition, compared to a normal diet. The 
authors suggested the necessity of conducting further 
larger studies to confirm this hypothesis[42]. Other 
authors pointed to a negative effect of sulfur products 
on UC course[43]. Sulfur and its compounds exert 
a negative effect on colonocytes by increasing the 
intestinal concentration of hydrogen sulfide. Sources 
of dietary sulfur include high protein products due to 
the presence of sulfur-containing amino acids and 
include red meat, cheese, eggs and nuts. Foods rich 
in inorganic sulfur compounds include the cruciferous 
vegetables and preserved products. According to 
Jowett et al[43], restricting dietary red meat intake 
(for reasons described above) may prolong periods 
of remission. In the same report, the authors did not 
find a negative effect of dairy product consumption 
on the course of the disease or a protective effect of a 
high fiber diet[43]. Contradictory results were obtained 
by Fernández-Bañares et al[44]. In the course of their 
study, they administered 10 g of psyllium seeds twice 
a day to UC patients and compared the effectiveness 
of such treatment with patients receiving 500 mg 
of mesalazine administered three times a day and 
with a third group of patients receiving fiber and 
mesalazine. After 12 mo, recurrent disease was noted 
in 40% of patients in the fiber group, 35% in the 
mesalazine group, and 30% in the combined group. 
Based on these results, the authors concluded that a 
high fiber diet may prevent recurrent UC in a manner 
comparable to mesalazine[44]. The above conclusion 
was confirmed by Hallert et al[45] who also pointed to a 
beneficial effect of psyllium seed husks on amelioration 
of UC symptoms in patients in remission. Based on a 
review, Wedlake et al[46] indicated a mildly beneficial 
effect of fiber on the course of UC. The results 
obtained for CD patients did not indicate a positive 
role for a high fiber diet in improving clinical status[46]. 
On the other hand, other studies demonstrated a 
beneficial effect of a high fiber diet on gastrointestinal 
function in CD patients, which was based on the 
Inflammatory Bowel Disease Questionnaire and the 
Harvey Bradshaw Index[47]. This nutritional model 
did not result in adverse effects; however, it did not 
affect inflammatory markers (no differences were 
noted between C-reactive protein levels in the study 
Owczarek D et al . Diet and nutritional factors in IBD
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and control groups), which may suggest its limited 
importance in the course of CD[47].
Germinated barley foodstuff (GBF) is a source of 
fiber and glutamine-rich protein. GBF is a prebiotic 
product that increases butyrate production by 
intestinal bacteria. These compounds may affect the 
repair and restoration of function of colonocytes[48]. 
In their limited study, Bamba et al[49] administered 
20-30 g of GBF to patients with mild or moderate 
UC exacerbation. After 4 wk of therapy, the patients 
demonstrated clinical and endoscopic improvements, 
thus indicating that GBF may play an important role in 
IBD therapy[49]. Hanai et al[50] confirmed these results 
by demonstrating a beneficial effect of supplementing 
a standard therapy with 20 g of GBF. Patients 
receiving prebiotic supplementation demonstrated an 
improvement of clinical status as well as prolonged 
remission. The above results require confirmation in a 
large scale study.
Some studies pointed to a negative effect of alcohol 
consumption on the course of IBD. According to 
Swanson et al[51], in patients with non-active UC and 
CD, alcohol resulted in exacerbation of gastrointestinal 
symptoms. Moreover, Jowett et al[43] indicated that 
alcohol consumption increased the risk of disease 
exacerbation in patients with UC.
Attempts have also been made at implementing 
detailed diets to supplement IBD therapy. Olendzki et 
al[52] used a specially developed menu low in refined 
sugars, rich in prebiotic and probiotic products and 
characterized by an appropriate ratio of fatty acids. 
Of 40 patients included in the study, 13 abandoned 
the diet early and 24 demonstrated a very good or 
good response to the diet based on self-assessment 
of disease symptoms and adherence to the principles 
of the diet. Three patients showed an ambiguous or 
negative response. Of all the participants, the case 
histories of 11 patients for whom complete data were 
available were analyzed. In these patients, when the 
diet was employed for 4 wk or longer, IBD symptom 
reduction was noted based on the Harvey Bradshaw 
Index and the Modified Truelove and Witts Severity 
Index. All patients were able to discontinue at least 
one of their previously used IBD medications. This 
example indicates the possibility of deriving additional 
benefits from supplementing pharmacotherapy by an 
appropriately composed diet[52]. Moreover, Cohen et 
al[15], prescribed pediatric patients with a SCD diet. 
The patients restricted refined sugar and complex 
carbohydrate consumption and those that followed the 
diet for 12-52 wk showed an improved clinical status. 
A similar problem was addressed by Suskind et al[53] 
when they analyzed the effect of the SCD diet on CD 
course in pediatric patients for 5-30 mo. Improvements 
in clinical status were seen in the patients following the 
SDC diet[53]. The results of these two studies require 
confirmation of the effectiveness and safety of the SCD 
diet in a larger group of patients.
Chiba et al[54] investigated the effect of a semi-
vegetarian diet (SVD) on maintaining CD remission. 
Sixteen patients continued the recommended diet 
after discharge from hospital. The percentage of 
remission achieved in the study group was 100% after 
one year of starting the SVD and 92% after two years. 
Based on these observations, the authors recognized 
the SVD as a highly effective diet in maintaining CD 
remission[54].
Another type of diet employed for IBD therapy 
is the FODMAP diet, which is low in fermentable 
oligosaccharides, disaccharides, monosaccharides 
and polyols[16]. This nutritional model is based on a 
theory suggesting that poorly absorbed carbohydrates 
become a medium for bacteria and may cause 
excessive growth of intestinal flora, and was originally 
recommended for use in irritable bowel syndrome 
patients. Gearry et al[16] assessed the effect of the diet 
on the course of IBD; the study included 52 patients 
with CD and 20 individuals with UC. Approximately 
50% of patients noted a decrease in abdominal pain, 
flatulence and diarrhea. Thus, the FODMAP diet is 
recognized to be helpful for patients with IBD with 
concomitant functional intestinal symptoms[16].
In these studies, the investigators evaluated the 
effect of various nutrients and detailed diets on the 
course of IBD. Despite the lack of tangible dietary 
recommendations for patients suffering from UC 
and CD, it is important to take into account the 
possibility of developing deficiencies associated with 
gastrointestinal status, administered medications, 
past surgical procedures or limited appetite[12]. While 
planning a diet, it is necessary to pay particular 
attention to key nutrients.
KEY NUTRIENTs IN THE DIET Of IBD 
paTIENTs
When recommending a given diet to an IBD patient, 
emphasis should be placed on adequate caloric supply 
as well as the content of iron, calcium, vitamins D, B12 
and A, folic acid and zinc[12].
Energy
Malnutrition may affect 20%-85% of CD patients[55]. 
Therefore it is important that their diet be appro-
priately planned. Of significance is an appropriate 
supply of energy, vitamins and minerals as deficiencies 
in these may develop during the course of the 
disease. Loss of appetite may hinder the consumption 
of an adequate amount of food. For this reason, the 
European Society for Clinical Nutrition and Metabolism 
recommends an intake of up to 600 kcal/d in the 
form of oral nutritional supplements[55] since the 
consequences of nutritional deficiencies may include 
anemia, osteomalacia, osteoporosis and problems 
Owczarek D et al . Diet and nutritional factors in IBD
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with mesopic vision[55].
Iron
Anemia often coexists with IBD, affecting 21%-88% 
of IBD patients[4,55-57]. The principal cause of anemia is 
iron deficiency (approximately 57%) but it may also 
be caused by a chronic inflammatory state or be due 
to vitamin B12 deficiency[56]. According to the World 
Health Organization recommendations, excessively 
low hemoglobin (Hb) concentrations occur when Hb 
levels drop below 11-13 g/dL (depending on sex 
and age group). Determining the changes in ferritin 
levels allows for differentiating between various types 
of anemia. Decreased concentrations of the protein 
are observed in anemia caused by iron deficiency, 
while in patients with inflammatory states, ferritin 
concentrations are elevated. Due to a poor tolerance 
of oral iron preparations and the risk of exacerbation 
of the gastrointestinal inflammatory state, intravenous 
preparations are administered for anemia treatment in 
patients with IBD[56,57].
Calcium
Patients with IBD are at risk of developing oste-
oporosis. This is related to malnutrition which is 
common in this group and to problems with absorption 
of nutrients[55], also due to the administration of 
glucocorticosteroids. For the above reasons, it is 
important that an adequate dietary calcium supply 
of 1000-1500 mg/d is attained. Patients with IBD 
often give up milk and dairy products for fear of 
lactose consumption. It should be emphasized that 
intolerance of the disaccharide is not more common in 
this patient population compared to healthy subjects 
and its occurrence is affected by age and ethnic factors 
rather than by IBD alone[12,58-60]. In cases of lactose 
intolerance or problems with dietary calcium supply, 
calcium supplementation should be considered.
Vitamin D
Vitamin D is a fat-soluble vitamin whose role in the 
development of IBD has long been underestimated; its 
levels are associated with IBD morbidity and course. 
Vitamin D deficiency facilitates the development of CD 
and UC and may worsen their course[13,14]. Jørgensen 
et al[14] examined patients with CD and demonstrated 
an inverse relationship between serum vitamin D 
levels and disease activity. Hlavaty et al[61] carried out 
a study among patients with IBD using a questionnaire 
evaluating “health-related quality of life”. They 
demonstrated a decrease in the evaluated parameters 
in the winter/spring period, which correlated with 
a decreased serum vitamin D concentration. CD 
patients may develop vitamin D deficiency due to 
malabsorption[55]. Such a deficiency, as demonstrated 
by Abraham et al[62], facilitates the loss of bone 
mineral density. Vitamin D supplementation may be 
introduced; studies point to a positive effect of such 
an intervention exerted on the disease course[63]. In 
their study, Jørgensen et al[63] administered vitamin 
D at a dose of 1200 IU to CD patients. After three 
months of treatment, recurrent disease was noted in 
13% (6/46) of the study group patients as opposed 
to 29% (14/48) of the subjects in the control group. 
The authors stressed the necessity of confirming 
their results in a larger study. In turn, Pappa et al[64] 
administered different doses of vitamin D to two 
groups of pediatric patients aged 8-18 years. Group 
A received 400 IU daily, all year long and, depending 
on the season of the year, Group B received 1000 IU 
(summer/autumn) or 2000 IU (winter/spring). The 
doses were selected in a way that allowed the target 
serum vitamin concentration value (> 32 ng/mL) to 
be achieved in only 3% of patients in both groups. 
The authors observed lower C-reactive protein and 
interleukin-6 levels in the patients receiving higher 
doses of the vitamin. These results may indicate a 
beneficial effect of vitamin D supplementation on IBD-
associated inflammatory processes; however, these 
observations require confirmation. Dadaei et al[65] 
administered vitamin D at a dose of 50000 IU per 
week for 12 wk, resulting in increased serum levels 
and decreased levels of tumor necrosis factor (TNF-α). 
However, the decrease in TNF-α levels did not reach 
statistical significance.
Other studies have observed an increased risk of 
Clostridium difficile infections and development of 
cancers (especially colon cancer) in IBD patients with 
decreased vitamin D levels[66,67]. In view of the growing 
number of publications on the role of vitamin D in 
IBD and continued doubts surrounding the selection 
of an appropriate dose, further studies on vitamin D 
supplementation are warranted.
B vitamins
B vitamin deficiencies in patients with CD are 
also frequent (B12: 28%-48% and folic acid: 
4.3%-54%)[19,55]. Problems with cyanocobalamin ab-
sorption may occur after resection of the distal part 
of the intestine or with particularly intensified disease 
involving the distal gastrointestinal tract. The risk of 
folic acid deficiency increases in patients treated with 
sulphasalazine[19]. Deficiencies of B vitamins may 
facilitate the development of macrocytic anemia and 
hyperhomocysteinemia. For this reason, the level of 
cyanocobalamin should be monitored and vitamin B12 
preparations should be administered parenterally if 
needed in order to treat the deficiency. Patients who 
are at risk for folate deficiency should supplement with 
folic acid when necessary[19,55].
Deficiencies of other vitamins and minerals
Patients with CD may also present with zinc (70% of 
males) and magnesium deficiencies[11,19]. Moreover, 
vitamin A deficiency may occur during phases of active 
disease[19]. A well planned diet should include foods 
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that are rich in these components, such as β-carotene-
containing vegetables (carrots, red peppers), nuts, 
groats and wholegrain products[68].
aDDITIONal sUpplEmENTaTION IN IBD
Numerous reports have investigated employing 
additional supplementation with components that may 
shorten the duration of exacerbated disease periods or 
that prolong phases of remission. Particular attention 
has been given to preparations containing probiotics 
and unsaturated omega-3 fatty acids.
Probiotics
IBD morbidity may be related to gastrointestinal 
bacterial flora abnormalities and to an abnormal 
immune response to physiological flora[4,69]. For these 
reasons, investigations were carried out to determine 
the effects of probiotic supplementation on the course 
of UC and CD. Specifically, the effects of various 
probiotics on achieving and maintaining IBD remission 
were studied. The results differed depending on the 
bacterial strain and type of disease and contradictory 
results were obtained for some probiotics. In their 
review paper, Jonkers et al[17] demonstrated a lack 
of sufficient evidence in support of the beneficial 
effects of probiotic supplementation in CD. At the 
same time, the authors emphasized promising 
results of studies on the Escherichia coli strain Nissle 
1917 for the prevention of disease exacerbation and 
on a multi-strain product containing Lactobacillus 
acidophilus, Lactobacillus plantarum, Lactobacillus 
casei, Lactobacillus bulgaricus, Bifidobacterium breve, 
Bifidobacterium longum, Bifidobacterium infantis and 
Streptococcus thermophilus (VSL#3) during active 
and inactive phases of UC[17]. Additionally, a meta-
analysis by Shen et al[70] and a study by Miele et al[71] 
indicated a beneficial effect of supplementation with 
VSL#3 on achieving and maintaining UC remission. 
Other probiotic strains that fostered the interest of 
investigators include Lactobacillus GG (LGG) and 
Saccharomyces boulardii (SB)[72]. A study administered 
a dose of 1 g/d of Saccharomyces boulardii to patients 
in CD remission; however, no beneficial effects were 
found on the course of CD compared with placebo. 
Differences in the response to supplementation were 
shown solely in non-smoking patients; an effect 
that requires future investigation[72]. Guslandi et 
al[73,74] performed two small scale studies (32 and 
25 individuals) that found a beneficial effect of SB 
supplementation in maintaining remission of CD 
and UC. In both studies, the probiotic was given 
in addition to mesalazine therapy. Gupta et al[75] 
administered LGG to four children with CD at a dose 
of 1010 colony forming units, twice a day, for six 
months. Based on the decrease in the initial values 
of the Pediatric Crohn’s Disease Activity Index, the 
investigators found a decrease in disease activity in 
their patients. Additionally, a reduction in the dose 
of glucocorticosteroids given was achieved in three 
participants. On the other hand, a study by Bousvaros 
et al[76] employing the same strain in a group of 75 
children with CD found no effect of supplementation on 
prolonging remission. Similar results indicating lack of 
effectiveness of LGG in CD were obtained by Prantera 
et al[77].
To date, despite solid theoretical foundations, 
no beneficial effects of probiotic supplementation 
on the course of IBD have been unambiguously 
demonstrated. The most promising results have been 
achieved when probiotic preparations containing the 
given bacterial strains were employed in UC[17,69-71].
Unsaturated omega-3 fatty acids
Other nutritional components that may affect the 
course of IBD are polyunsaturated omega-3 fatty 
acids (n-3 PUFA). These fatty acids have been studied 
for their anti-inflammatory activity[18]. In a review, 
Farrukh and Mayberry described a slight beneficial 
effect of PUFA supplementation during active disease. 
The results of various studies have pointed to a 
faster achievement of remission and the possibility 
of reducing the dose of glucocorticosteroids with n-3 
PUFA supplementation. However, the majority of 
studies have not confirmed the effects of PUFA on 
maintaining IBD remission. Less convincing results 
were obtained of the effects of n-3 PUFA on CD. 
Nevertheless, supplementation did achieve positive 
results in some studies. Further trials are warranted to 
determine the beneficial effects of omega-3 fatty acids 
on the disease course of IBD[18,55].
Protective factors Nutrients increasing IBD morbidity
Breastfeeding Cholesterol
Fiber Animal fats
Vitamin D Linoleic and arachidonic acids
Appropriate fluid supply Monosaccharides (ambiguous study 
results)
Vitamin C
Fruits (especially citrus fruits)
Magnesium
IBD: Inflammatory bowel diseases.
Table 2  Diet to be employed during disease exacerbation 
periods
Beneficial effect Negative effect
Solely enteral feeding (EEN) (in 
case of Crohn's disease, especially 
in pediatric patients)
Fiber (exception - patients 
with ulcerative proctitis with 
concomitant constipation)
Owczarek D et al . Diet and nutritional factors in IBD
Table 4  Key nutrients and dietary supplements in inflam­
matory bowel diseases patients
Table 3  Diet to be employed during remissions
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CONClUsION
Dietary factors play an underestimated role in the 
etiopathogenesis and course of IBD. The effects 
of numerous nutritional factors have been well 
documented (Tables 1, 2, 3 and 4).
Employing an appropriate diet may decrease 
the risk of developing IBD, which may be of special 
importance for individuals affected by such diseases. 
In particular, appropriate nutrition during periods of the 
disease may facilitate achieving or prolonging stages 
of remission and, importantly, improve comfort and 
quality of life.
However, there is no single diet suitable for all IBD 
patients; unique dietary recommendations must be 
developed for each patient, depending on the course 
of the disease, past surgical procedures and type of 
pharmacotherapy used.
For the above reasons, dietary recommendations 
should be treated as supplementation of pharma-
cotherapy in IBD.
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